Related Experiment Video

Updated: Mar 19, 2026

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

10.4K

The protein phosphatase 4 - PEA15 axis regulates the survival of breast cancer cells

Hiba N Mohammed1, Mark R Pickard2, Mirna Mourtada-Maarabouni1

  • 1School of Life Sciences, Faculty of Natural Sciences, Keele University, Keele, Staffordshire ST5 5BG, United Kingdom.

Cellular Signalling
|June 19, 2016
PubMed
Abstract

Insights

Protein phosphatase 4 (PP4c) inhibits breast cancer cell growth and survival. This occurs via the de-phosphorylation of PEA15, a key regulator of apoptosis, highlighting a novel PP4c-PEA15 signaling axis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Breast cancer progression is linked to dysregulated cell survival pathways.
  • Protein kinases and phosphatases control cell fate through phosphorylation.
  • Protein phosphatases, particularly PP4, are understudied in breast cancer.

Purpose of the Study:

  • Investigate the role of serine/threonine protein phosphatase 4 (PP4c) in breast cancer cell survival.
  • Elucidate the signaling mechanisms by which PP4c influences breast cancer progression.

Main Methods:

  • Utilized breast cancer cell lines (MCF7, MDA-MB-231) with PP4c overexpression or siRNA knockdown.
  • Assessed cell viability, apoptosis, migration, and cell cycle.
  • Investigated the interaction between PP4c and PEA15 using immunoblotting and siRNA silencing.

Main Results:

  • PP4c overexpression inhibited proliferation, increased apoptosis, and reduced migration and colony formation.
  • PP4c knockdown had complementary effects, promoting cancer cell growth.
  • PP4c regulates PEA15 phosphorylation, and this interaction is crucial for PP4c's anti-cancer effects.

Conclusions:

  • PP4c significantly regulates breast cancer cell survival and growth.
  • Identified a novel signaling axis: PP4c-PEA15, which controls breast cancer cell fate.
  • Dysfunction of the PP4c-PEA15 axis may contribute to breast cancer development and progression.
Keywords:
PEA15, cell survivalPP4PP4cbreast cancer

More Related Videos

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors10:17

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors

Published on: April 29, 2022

2.9K
Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.7K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.7K